TCTR20220101003已完成不适用
The Outcomes of Convalescent Plasma Therapy in Severe COVID-19 Patients Compared with Standard of Care; a Case-control Study
Center of Learning and Research in Celebration of HRH Princess Chulabhorn 60th Birthday Anniversary0 个研究点目标入组 107 人开始时间: 2022年1月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 107
研究概览
简要总结
The CPT study demonstrated lower mortality (15%) in the CPT arm with a low hazard ratio in Cox-regression univariate and multivariate analysis.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 17 Years 至 100 Years（—）
- 性别
- All
入选标准
- •107 cases compatible with severe COVID-19 definition
排除标准
- •Excluded 1,261 of mild cases
- •-Excluded 1,260 of moderate cases
- •-Exclude 40 of severe cases
研究者
相似试验
已完成
不适用
Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19Coronavirus Disease 2019 (COVID-19)NCT04545047VA Office of Research and Development5,044
终止
3 期
Early Convalescent Plasma Therapy for High-risk Patients With COVID-19 in Primary Care (the CoV-Early Study)Covid19NCT04589949Erasmus Medical Center420
已完成
2 期
Efficacy of Combined Convalescent Plasma Therapy with Oral RNA-dependent RNA Polymerase Inhibitor versus Monoclonal Neutralizing Antibody Therapy among Mild to Moderate COVID-19 in Outpatients: Multicenter, Non-inferiority, Open-label Randomized Controlled TrialMild to moderate COVID-19 (non-severe COVID-19)COVID-19, SARS-CoV-2, favipiravir, sotrovimab, convalescent plasma therapy, monoclonal neutralizing antibodyTCTR20220319002Chulabhorn Royal Academy136
已完成
2 期
Effect of convalescent plasma in COVID-19 patientsCTRI/2020/04/024706Institute of Liver and Biliary Sciences29
已完成
不适用
Effectiveness of Convalescent Plasma Therapy in 8 Non-Intubated COVID-19 Patients in Indonesia: A Case SeriesInfectious DiseaseNCT05046652Maranatha Christian University8